WO2001090346A3 - Gene recombination and hybrid protein development - Google Patents

Gene recombination and hybrid protein development Download PDF

Info

Publication number
WO2001090346A3
WO2001090346A3 PCT/US2001/016831 US0116831W WO0190346A3 WO 2001090346 A3 WO2001090346 A3 WO 2001090346A3 US 0116831 W US0116831 W US 0116831W WO 0190346 A3 WO0190346 A3 WO 0190346A3
Authority
WO
WIPO (PCT)
Prior art keywords
locations
crossover
methods
directed evolution
crossover locations
Prior art date
Application number
PCT/US2001/016831
Other languages
French (fr)
Other versions
WO2001090346A2 (en
Inventor
Zhen-Gang Wang
Christopher A Voigt
Stephen L Mayo
Frances H Arnold
Original Assignee
California Inst Of Techn
Zhen-Gang Wang
Christopher A Voigt
Stephen L Mayo
Frances H Arnold
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by California Inst Of Techn, Zhen-Gang Wang, Christopher A Voigt, Stephen L Mayo, Frances H Arnold filed Critical California Inst Of Techn
Priority to AU2001263411A priority Critical patent/AU2001263411A1/en
Priority to CA002405520A priority patent/CA2405520A1/en
Priority to EP01937702A priority patent/EP1283877A2/en
Publication of WO2001090346A2 publication Critical patent/WO2001090346A2/en
Publication of WO2001090346A3 publication Critical patent/WO2001090346A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102Mutagenizing nucleic acids
    • C12N15/1027Mutagenizing nucleic acids by DNA shuffling, e.g. RSR, STEP, RPR
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B10/00ICT specially adapted for evolutionary bioinformatics, e.g. phylogenetic tree construction or analysis
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G16B30/10Sequence alignment; Homology search
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G16B30/20Sequence assembly
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00ICT specially adapted for sequence analysis involving nucleotides or amino acids

Abstract

The invention relates to improved methods for directed evolution of polymers, including directed evolution of nucleic acids and proteins. Specifically, the methods of the invention include analytical methods for identifying 'crossover locations' in a polymer. Crossovers at these locations are less likely to disrupt desirable properties of the protein, such as stability or functionality. The invention further provides improved methods for directed evolution wherein the polymer is selectively recombined at the identified 'crossover locations'. Crossover disruption profiles can be used to identify preferred crossover locations. Structural domains of a biopolymer can also be identified and analyzed, and domains can be organized into schema. Schema disruption profiles can be calculated, for example based on conformational energy or interatomic distances, and these can be used to identify preferred or candidate crossover locations. Computer systems for implementing analytical methods of the invention are also provided.
PCT/US2001/016831 2000-05-23 2001-05-23 Gene recombination and hybrid protein development WO2001090346A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU2001263411A AU2001263411A1 (en) 2000-05-23 2001-05-23 Gene recombination and hybrid protein development
CA002405520A CA2405520A1 (en) 2000-05-23 2001-05-23 Gene recombination and hybrid protein development
EP01937702A EP1283877A2 (en) 2000-05-23 2001-05-23 Gene recombination and hybrid protein development

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US20704800P 2000-05-23 2000-05-23
US60/207,048 2000-05-23
US23596000P 2000-09-27 2000-09-27
US60/235,960 2000-09-27
US28356701P 2001-04-13 2001-04-13
US60/283,567 2001-04-13

Publications (2)

Publication Number Publication Date
WO2001090346A2 WO2001090346A2 (en) 2001-11-29
WO2001090346A3 true WO2001090346A3 (en) 2002-10-10

Family

ID=27395018

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/016831 WO2001090346A2 (en) 2000-05-23 2001-05-23 Gene recombination and hybrid protein development

Country Status (5)

Country Link
US (1) US20020045175A1 (en)
EP (1) EP1283877A2 (en)
AU (1) AU2001263411A1 (en)
CA (1) CA2405520A1 (en)
WO (1) WO2001090346A2 (en)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6991922B2 (en) 1998-08-12 2006-01-31 Proteus S.A. Process for in vitro creation of recombinant polynucleotide sequences by oriented ligation
US6951719B1 (en) 1999-08-11 2005-10-04 Proteus S.A. Process for obtaining recombined nucleotide sequences in vitro, libraries of sequences and sequences thus obtained
US6917882B2 (en) * 1999-01-19 2005-07-12 Maxygen, Inc. Methods for making character strings, polynucleotides and polypeptides having desired characteristics
US7024312B1 (en) * 1999-01-19 2006-04-04 Maxygen, Inc. Methods for making character strings, polynucleotides and polypeptides having desired characteristics
US7430477B2 (en) 1999-10-12 2008-09-30 Maxygen, Inc. Methods of populating data structures for use in evolutionary simulations
WO2001075767A2 (en) * 2000-03-30 2001-10-11 Maxygen, Inc. In silico cross-over site selection
AU2002251710A1 (en) * 2000-11-10 2002-07-30 The Penn State Research Foundation A modeling framework for predicting the number, type, and distribution of crossovers in directed evolution experiments
US7711490B2 (en) 2001-01-10 2010-05-04 The Penn State Research Foundation Method and system for modeling cellular metabolism
US20040142433A1 (en) * 2001-02-02 2004-07-22 Padgett Hal S. Polynucleotide sequence variants
DE60234159D1 (en) * 2001-02-02 2009-12-10 Large Scale Biology Corp METHOD OF INCREASING COMPLEMENTARITY IN A HETERODUPLEX POLYNUCLEOTIDE
US7582423B2 (en) * 2001-02-02 2009-09-01 Novici Biotech Llc Population of polynucleotide sequence variants
US7838219B2 (en) * 2001-02-02 2010-11-23 Novici Biotech Llc Method of increasing complementarity in a heteroduplex
US7465567B2 (en) * 2001-04-16 2008-12-16 California Institute Of Technology Peroxide-driven cytochrome P450 oxygenase variants
WO2002090496A2 (en) * 2001-05-03 2002-11-14 Rensselaer Polytechnic Institute Novel methods of directed evolution
US20030157495A1 (en) * 2002-02-01 2003-08-21 Padgett Hal S. Nucleic acid molecules encoding CEL I endonuclease and methods of use thereof
US7078211B2 (en) 2002-02-01 2006-07-18 Large Scale Biology Corporation Nucleic acid molecules encoding endonucleases and methods of use thereof
DK2315145T3 (en) * 2002-03-01 2016-01-25 Codexis Mayflower Holdings Llc Methods, systems, and software for identifying the functional biomolecules
US20050084907A1 (en) * 2002-03-01 2005-04-21 Maxygen, Inc. Methods, systems, and software for identifying functional biomolecules
US7747391B2 (en) * 2002-03-01 2010-06-29 Maxygen, Inc. Methods, systems, and software for identifying functional biomolecules
WO2003078583A2 (en) 2002-03-09 2003-09-25 Maxygen, Inc. Optimization of crossover points for directed evolution
US20030211484A1 (en) * 2002-05-13 2003-11-13 Keith Ball Sequence lineage evaluation interface
EP1532516A4 (en) 2002-07-10 2007-05-23 Penn State Res Found Method for determining gene knockout strategies
US7826975B2 (en) 2002-07-10 2010-11-02 The Penn State Research Foundation Method for redesign of microbial production systems
WO2005007806A2 (en) * 2003-05-07 2005-01-27 Duke University Protein design for receptor-ligand recognition and binding
EP1639091B1 (en) 2003-06-17 2012-12-05 California University Of Technology Regio- and enantioselective alkane hydroxylation with modified cytochrome p450
DK1700119T3 (en) * 2003-12-18 2010-06-07 Genencor Int Beta-lactamase CD4 + T cell epitopes
US8715988B2 (en) * 2005-03-28 2014-05-06 California Institute Of Technology Alkane oxidation by modified hydroxylases
US8026085B2 (en) * 2006-08-04 2011-09-27 California Institute Of Technology Methods and systems for selective fluorination of organic molecules
US8252559B2 (en) * 2006-08-04 2012-08-28 The California Institute Of Technology Methods and systems for selective fluorination of organic molecules
JP2010515683A (en) * 2007-01-05 2010-05-13 ザ カリフォルニア インスティチュート オブ テクノロジー Method for producing new stabilized proteins
WO2008121435A2 (en) * 2007-02-02 2008-10-09 The California Institute Of Technology Methods for generating novel stabilized proteins
US20080268517A1 (en) * 2007-02-08 2008-10-30 The California Institute Of Technology Stable, functional chimeric cytochrome p450 holoenzymes
US8802401B2 (en) * 2007-06-18 2014-08-12 The California Institute Of Technology Methods and compositions for preparation of selectively protected carbohydrates
WO2009149218A2 (en) * 2008-06-03 2009-12-10 Codon Devices, Inc. Novel proteins and methods of designing and using same
US9322007B2 (en) 2011-07-22 2016-04-26 The California Institute Of Technology Stable fungal Cel6 enzyme variants
US9684771B2 (en) 2013-01-31 2017-06-20 Codexis, Inc. Methods, systems, and software for identifying bio-molecules using models of multiplicative form
USD815145S1 (en) * 2016-03-25 2018-04-10 Illumina, Inc. Display screen with application icon
USD815146S1 (en) * 2016-03-25 2018-04-10 Illimina, Inc. Display screen with application icon

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998041623A1 (en) * 1997-03-18 1998-09-24 Novo Nordisk A/S Shuffling of heterologous dna sequences
WO2000009755A2 (en) * 1998-08-12 2000-02-24 Pangene Corporation Domain specific gene evolution
WO2000018906A2 (en) * 1998-09-29 2000-04-06 Maxygen, Inc. Shuffling of codon altered genes
WO2001016810A2 (en) * 1999-08-31 2001-03-08 The European Molecular Biology Laboratory A computer-based method for macromolecular engineering and design
WO2001061344A1 (en) * 2000-02-17 2001-08-23 California Institute Of Technology Computationally targeted evolutionary design

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6395547B1 (en) * 1994-02-17 2002-05-28 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US6117679A (en) * 1994-02-17 2000-09-12 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US6365408B1 (en) * 1998-06-19 2002-04-02 Maxygen, Inc. Methods of evolving a polynucleotides by mutagenesis and recombination

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998041623A1 (en) * 1997-03-18 1998-09-24 Novo Nordisk A/S Shuffling of heterologous dna sequences
WO2000009755A2 (en) * 1998-08-12 2000-02-24 Pangene Corporation Domain specific gene evolution
WO2000018906A2 (en) * 1998-09-29 2000-04-06 Maxygen, Inc. Shuffling of codon altered genes
WO2001016810A2 (en) * 1999-08-31 2001-03-08 The European Molecular Biology Laboratory A computer-based method for macromolecular engineering and design
WO2001061344A1 (en) * 2000-02-17 2001-08-23 California Institute Of Technology Computationally targeted evolutionary design

Non-Patent Citations (11)

* Cited by examiner, † Cited by third party
Title
BOGARAD LEONARD D ET AL: "A hierarchical approach to protein molecular evolution.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES, vol. 96, no. 6, 16 March 1999 (1999-03-16), March 16, 1999, pages 2591 - 2595, XP002193260, ISSN: 0027-8424 *
CAMERI A ET AL: "Construction and evolution of antibody-phage libraries by DNA shuffling", NATURE MEDICINE, NATURE PUBLISHING, CO, US, vol. 2, no. 1, January 1996 (1996-01-01), pages 100 - 102, XP002098467, ISSN: 1078-8956 *
CHANG C-C J ET AL: "EVOLUTION OF A CYTOKINE USING DNA FAMILY SHUFFELING", NATURE BIOTECHNOLOGY, NATURE PUBLISHING, US, vol. 17, no. 8, August 1999 (1999-08-01), pages 793 - 797, XP000946490, ISSN: 1087-0156 *
DAHIYAT B I ET AL: "PROTEIN DESIGN AUTOMATION", PROTEIN SCIENCE, CAMBRIDGE UNIVERSITY PRESS, CAMBRIDGE, GB, vol. 5, no. 5, 1 May 1996 (1996-05-01), pages 895 - 903, XP002073372, ISSN: 0961-8368 *
HOLM LIISA ET AL: "Parser for protein folding units.", PROTEINS STRUCTURE FUNCTION AND GENETICS, vol. 19, no. 3, 1994, pages 256 - 268, XP001064311, ISSN: 0887-3585 *
NIGGEMANN MONIKA ET AL: "Exploring local and non-local interactions for protein stability by structural motif engineering.", JOURNAL OF MOLECULAR BIOLOGY., vol. 296, no. 1, 11 February 2000 (2000-02-11), pages 181 - 195, XP002193262, ISSN: 0022-2836 *
STREET ARTHUR G ET AL: "Computational protein design.", STRUCTURE (LONDON), vol. 7, no. 5, May 1999 (1999-05-01), pages R105 - R109, XP002193261, ISSN: 0969-2126 *
VOIGT C A ; MAYO S L ; ARNOLD F H ; WANG Z: "Computationally focusing the directed evolution of proteins.", JOURNAL OF CELLULAR BIOCHEMISTRY - SUPPLEMENT, vol. 37, 29 January 2002 (2002-01-29), pages 58 - 63, XP002193264 *
VOIGT C A ET AL: "TRADING ACCURACY FOR SPEED: A QUANTITATIVE COMPARISON OF SEARCH ALGORITHMS IN PROTEIN SEQUENCE DESIGN", JOURNAL OF MOLECULAR BIOLOGY, LONDON, GB, vol. 299, no. 3, 2000, pages 789 - 803, XP001061223, ISSN: 0022-2836 *
VOIGT CHRISTOPHER A ET AL: "Computational method to reduce the search space for directed protein evolution.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES, vol. 98, no. 7, 27 March 2001 (2001-03-27), March 27, 2001, pages 3778 - 3783, XP002193263, ISSN: 0027-8424 *
VOSE, M.D. AND LIEPENS, G.E.: "Schema disruption", 1991, MORGAN KAUFFMAN, SAN MATEO, CA, USA, XP001064313 *

Also Published As

Publication number Publication date
AU2001263411A1 (en) 2001-12-03
CA2405520A1 (en) 2001-11-29
WO2001090346A2 (en) 2001-11-29
EP1283877A2 (en) 2003-02-19
US20020045175A1 (en) 2002-04-18

Similar Documents

Publication Publication Date Title
WO2001090346A3 (en) Gene recombination and hybrid protein development
WO2003055978A3 (en) Gene recombination and hybrid protein development
ATE248224T1 (en) DETERMINATION OF MUTATIONS BY CLIVATION WITH RESOLVASE
NZ306767A (en) Method of identifying molecular interactions employing counterselection and at least two hybrid molecules or two hybrid systems
DE69902996T2 (en) MISCELLANEOUS DETECTION TECHNIQUES
WO2005042781A8 (en) Methods for producing a paired tag from a nucleic acid sequence and methods of use thereof
BR0016569A (en) RNA isolation process from embedded tissue specimens - fixed paraffin - formalin
WO2000065521A3 (en) System and method for polymer notation
WO2000012726A3 (en) Rationally designed heparinases derived from heparinase i and ii
EP1499885A4 (en) Novel fusion proteins and assays for molecular binding
ATE365228T1 (en) CELLULAR ARRAYS FOR IDENTIFYING ALTERED GENE EXPRESSION
CA2273078A1 (en) Use of nucleic acids bound to carrier macromolecules
WO2000066777A3 (en) Assay based on the analysis of dna melting curves
WO2002018948A3 (en) Differentially expressed epitopes and uses thereof
WO2001075157A1 (en) Probe for constructing probe polymer, method of constructing probe polymer and utilization thereof
Cui et al. JBP1-seq: a fast and efficient method for genome-wide profiling of 5hmC
Aliaga Goltsman et al. Novel type VA CRISPR effectors are active nucleases with expanded targeting capabilities
WO2001077379A3 (en) A method of cell detection
WO2001062965A3 (en) Differential expression screening method
Dainiak et al. Conjugates of monoclonal antibodies with polyelectrolyte complexes–an attempt to make an artificial chaperone
EP1041160A4 (en) Methods for detecting mutation in base sequence
Mondal et al. Macroaffinity Ligand‐Facilitated Three‐Phase Partitioning (MLFTPP) of α‐Amylases Using a Modified Alginate
WO2003091835A3 (en) Computationally targeted evolutionary design
WO2000040757A3 (en) Method of identifying nucleic acids
WO2001075149A3 (en) Biosensor, biosensor array and method for detecting macromolecular biopolymers with a biosensor

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2405520

Country of ref document: CA

AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2001263411

Country of ref document: AU

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 2001937702

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001937702

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2001937702

Country of ref document: EP